BusinessSpero Therapeutics Announces Positive Phase 1 Clinical Data From Potentiator PlatformBy Nasdaq OMXOct 3, 2017, 12:01 PM UTC
BusinessSpero Announces Appointment of Frank Thomas to its Board of Directors and Promotions within Leadership TeamBy Nasdaq OMXSep 6, 2017, 12:01 PM UTC
